The present study suggests that Cav‐3 OE does not augment the anti‐hypertrophic effect of basal Cav‐3 levels in sham myocytes, since cell volume and capacitance in the absence of TAC are similar in WT and OE myocytes. The gene discussed is CAV3; the disease is persistent truncus arteriosus.